These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 38879701)
1. Effect of dapagliflozin on ferroptosis through the gut microbiota metabolite TMAO during myocardial ischemia-reperfusion injury in diabetes mellitus rats. Wang L; Wang Y; Xu H; Li W Sci Rep; 2024 Jun; 14(1):13851. PubMed ID: 38879701 [TBL] [Abstract][Full Text] [Related]
2. Ferroptosis Is Involved in Diabetes Myocardial Ischemia/Reperfusion Injury Through Endoplasmic Reticulum Stress. Li W; Li W; Leng Y; Xiong Y; Xia Z DNA Cell Biol; 2020 Feb; 39(2):210-225. PubMed ID: 31809190 [TBL] [Abstract][Full Text] [Related]
3. Dapagliflozin Modulates the Fecal Microbiota in a Type 2 Diabetic Rat Model. Yang M; Shi FH; Liu W; Zhang MC; Feng RL; Qian C; Liu W; Ma J Front Endocrinol (Lausanne); 2020; 11():635. PubMed ID: 33312157 [No Abstract] [Full Text] [Related]
4. Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF- Liu L; Luo H; Liang Y; Tang J; Shu Y Comput Math Methods Med; 2022; 2022():3293054. PubMed ID: 35096128 [TBL] [Abstract][Full Text] [Related]
5. Oleanolic acid alleviating ischemia-reperfusion injury in rat severe steatotic liver via KEAP1/NRF2/ARE. Pi Y; Zuo H; Wang Y; Zheng W; Zhou H; Deng L; Song H Int Immunopharmacol; 2024 Sep; 138():112617. PubMed ID: 38972213 [TBL] [Abstract][Full Text] [Related]
6. Ozone Administration Reduces Myocardial Ischemia Reperfusion Injury in Streptozotocin Induced Diabetes Mellitus Rat Model. Gülcan MB; Demirtaş H; Özer A; Yığman Z; Dursun AD; Arslan M; Oktar GL Drug Des Devel Ther; 2024; 18():4203-4213. PubMed ID: 39319194 [TBL] [Abstract][Full Text] [Related]
7. Polyphenols from hickory nut reduce the occurrence of atherosclerosis in mice by improving intestinal microbiota and inhibiting trimethylamine N-oxide production. Jiang C; Wang S; Wang Y; Wang K; Huang C; Gao F; Peng Hu H; Deng Y; Zhang W; Zheng J; Huang J; Li Y Phytomedicine; 2024 Jun; 128():155349. PubMed ID: 38522315 [TBL] [Abstract][Full Text] [Related]
8. Activation of NRF2/FPN1 pathway attenuates myocardial ischemia-reperfusion injury in diabetic rats by regulating iron homeostasis and ferroptosis. Tian H; Xiong Y; Zhang Y; Leng Y; Tao J; Li L; Qiu Z; Xia Z Cell Stress Chaperones; 2021 Mar; 27(2):149-164. PubMed ID: 35124772 [TBL] [Abstract][Full Text] [Related]
9. Relationship between gut microbiota and type 2 diabetic erectile dysfunction in Sprague-Dawley rats. Li H; Qi T; Huang ZS; Ying Y; Zhang Y; Wang B; Ye L; Zhang B; Chen DL; Chen J J Huazhong Univ Sci Technolog Med Sci; 2017 Aug; 37(4):523-530. PubMed ID: 28786059 [TBL] [Abstract][Full Text] [Related]
10. Dapagliflozin Suppresses ER Stress and Improves Subclinical Myocardial Function in Diabetes: From Bedside to Bench. Shih JY; Lin YW; Fisch S; Cheng JT; Kang NW; Hong CS; Chen ZC; Chang WT Diabetes; 2021 Jan; 70(1):262-267. PubMed ID: 33115828 [TBL] [Abstract][Full Text] [Related]
11. Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis Chen W; Zhang Y; Wang Z; Tan M; Lin J; Qian X; Li H; Jiang T Front Pharmacol; 2023; 14():1078205. PubMed ID: 36891270 [TBL] [Abstract][Full Text] [Related]
12. Effect of extracellular matrix stiffness on efficacy of Dapagliflozin for diabetic cardiomyopathy. Zhu T; Ye Z; Song J; Zhang J; Zhao Y; Xu F; Wang J; Huang X; Gao B; Li F Cardiovasc Diabetol; 2024 Jul; 23(1):273. PubMed ID: 39049086 [TBL] [Abstract][Full Text] [Related]
13. Dapagliflozin Ameliorates Renal Tubular Ferroptosis in Diabetes via SLC40A1 Stabilization. Huang B; Wen W; Ye S Oxid Med Cell Longev; 2022; 2022():9735555. PubMed ID: 35993021 [TBL] [Abstract][Full Text] [Related]
14. SGLT2 inhibition via dapagliflozin improves generalized vascular dysfunction and alters the gut microbiota in type 2 diabetic mice. Lee DM; Battson ML; Jarrell DK; Hou S; Ecton KE; Weir TL; Gentile CL Cardiovasc Diabetol; 2018 Apr; 17(1):62. PubMed ID: 29703207 [TBL] [Abstract][Full Text] [Related]
15. SGLT2 inhibitor dapagliflozin reduces endothelial dysfunction and microvascular damage during cardiac ischemia/reperfusion injury through normalizing the XO-SERCA2-CaMKII-coffilin pathways. Ma L; Zou R; Shi W; Zhou N; Chen S; Zhou H; Chen X; Wu Y Theranostics; 2022; 12(11):5034-5050. PubMed ID: 35836807 [No Abstract] [Full Text] [Related]
16. Dapagliflozin attenuates AKI to CKD transition in diabetes by activating SIRT3/PGC1-α signaling and alleviating aberrant metabolic reprogramming. Li H; Xia Y; Zha H; Zhang Y; Shi L; Wang J; Huang H; Yue R; Hu B; Zhu J; Song Z Biochim Biophys Acta Mol Basis Dis; 2024 Oct; 1870(7):167433. PubMed ID: 39067538 [TBL] [Abstract][Full Text] [Related]
17. Trimethylamine-N-oxide (TMAO) response to animal source foods varies among healthy young men and is influenced by their gut microbiota composition: A randomized controlled trial. Cho CE; Taesuwan S; Malysheva OV; Bender E; Tulchinsky NF; Yan J; Sutter JL; Caudill MA Mol Nutr Food Res; 2017 Jan; 61(1):. PubMed ID: 27377678 [TBL] [Abstract][Full Text] [Related]
18. N-acetylcysteine Protects Against Myocardial Ischemia-Reperfusion Injury Through Anti-ferroptosis in Type 1 Diabetic Mice. Zhou D; Yang Y; Chen J; Zhou J; He J; Liu D; Zhang A; Yuan B; Jiang Y; Xia W; Han R; Xia Z Cardiovasc Toxicol; 2024 May; 24(5):481-498. PubMed ID: 38647950 [TBL] [Abstract][Full Text] [Related]
19. Metformin alleviates choline diet-induced TMAO elevation in C57BL/6J mice by influencing gut-microbiota composition and functionality. Su C; Li X; Yang Y; Du Y; Zhang X; Wang L; Hong B Nutr Diabetes; 2021 Jul; 11(1):27. PubMed ID: 34389700 [TBL] [Abstract][Full Text] [Related]
20. A novel therapeutic combination of dapagliflozin, Lactobacillus and crocin attenuates diabetic cardiomyopathy in rats: Role of oxidative stress, gut microbiota, and PPARγ activation. Khalaf EM; Hassan HM; El-Baz AM; Shata A; Khodir AE; Yousef ME; Elgharabawy RM; Nouh NA; Saleh S; Bin-Meferij MM; El-Kott AF; El-Sokkary MMA; Eissa H Eur J Pharmacol; 2022 Sep; 931():175172. PubMed ID: 35944619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]